Aging and IL-7 mediated CD8+ T cell survival

衰老和 IL-7 介导的 CD8 T 细胞存活

基本信息

  • 批准号:
    10207438
  • 负责人:
  • 金额:
    $ 36.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-15 至 2023-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract: Alterations in the immune system occur with aging, likely contributing to the development of infections and malignancies. Although the latter finding suggests an age-associated decline of the immune system, aging could be regarded as a condition with dysregulated inflammation (inflammaging). In T cell immunity, probably, the most prominent change with aging is the expansion of memory CD8+ T cells in peripheral blood although its exact mechanism(s) and significance are yet to be determined. My lab investigated whether the expansion of human memory CD8+ T cells with aging was secondary to increased expression of IL-7 receptor alpha chain (IL-7Rα) which dictates the response to the pro-survival cytokine IL-7. We found two cell populations which expressed low and high levels of IL-7Rα (IL-7Rαlow and high) in effector memory (EM) CD8+ T cells in peripheral blood. Of interest, older adults (OA, age ≥ 65) had expansion of IL- 7Rαlow EM CD8+ T cells (up to 70% of total CD8+ T cells), which are largely cytotoxic and inflammatory cytokine producing cells, compared to young adults (YA, age ≤ 40). Such cell expansion is associated with cytomegalovirus infection, which persists for lifetime, as well as with enhanced production of and proliferative response to IL-15 that promotes the maintenance and effector function of memory CD8+ T cells. However, the significance of the expansion of IL-7Rαlow EM CD8+ T cells in OA remains largely unknown, especially in the context of inflammation. To address this critical question, we performed a genome-wide DNA methylation analysis in IL-7Rαlow and high EM CD8+ T cells since DNA methylation modulates gene expression. IL-7Rαlow EM CD8+ T cells have hypomethylation of DNA in a group of chemotaxis-associated genes, including CX3CR1 (receptor for fractalkine), with enhanced expression. Plus, we noticed increased CX3CR1 expression by IL- 7Rαlow EM CD8+ T cells in OA compared to YA as well as the effect of aging on DNA methylation of the CX3CR1 promoter in the same cells. Thus, we hypothesize that aging “qualitatively” enhances the pro- inflammatory traits of human IL-7Rαlow EM CD8+ T cells by affecting gene regulatory mechanisms, including DNA methylation and IL-15-mediated responses in addition to expanding them and that soluble factors produced from such cells promote inflammation by activating other cells. This hypothesis will be tested with: Aim 1. Investigate whether aging promotes IL-7Rαlow EM CD8+ T cell-mediated inflammatory response in humans by altering inflammatory gene regulation via DNA methylation and transcription factors; Aim 2. Elucidate age-associated alterations in IL-15-mediated inflammatory response in human IL-7Rαlow EM CD8+ T cells; and Aim 3. Investigate the significance of age-associated alterations of IL-7Rαlow EM CD8+ T cells in promoting inflammatory responses using ex vivo bioassay and humanized mice. Our results will shed light on the biological significance of expanded memory CD8+ T cells with aging, especially in the aspect of inflammation, as well as on the possible role of gene regulations in promoting this process.
项目摘要/摘要:免疫系统的改变随着年龄的增长而发生,可能导致 感染和恶性肿瘤的发展。尽管后一项发现表明, 在免疫系统中,衰老可以被认为是具有失调的炎症(炎症)的状况。在 随着年龄的增长,T细胞免疫可能最突出的变化是记忆性CD 8 + T细胞的扩增, 外周血,尽管其确切的机制和意义还有待确定。我的实验室 研究人类记忆性CD 8 + T细胞随着衰老的扩增是否继发于增加 IL-7受体α链(IL-7 R α)的表达,决定了对促存活细胞因子IL-7的应答。 我们发现两个细胞群表达低和高水平的IL-7 R α(IL-7 R α低和高), 外周血中的记忆(EM)CD 8 + T细胞。值得注意的是,老年人(OA,年龄≥ 65岁)的IL-10水平增加, 7 R α降低EM CD 8 + T细胞(高达总CD 8 + T细胞的70%),其主要是细胞毒性和炎性细胞因子 与年轻人(YA,年龄≤ 40岁)相比,这种细胞扩张与 巨细胞病毒感染,持续终身,以及与增强的生产和增殖 免疫调节剂是对IL-15的应答,其促进记忆性CD 8 + T细胞的维持和效应子功能。但 在OA中IL-7 R α低EM CD 8 + T细胞扩增的意义在很大程度上仍然未知,特别是在 炎症的背景。为了解决这个关键问题,我们进行了全基因组DNA甲基化, 分析IL-7 R α低和高EM CD 8 + T细胞,因为DNA甲基化调节基因表达。IL-7 R α低 EM CD 8 + T细胞在一组趋化相关基因中具有DNA低甲基化,包括CX 3CR 1 (fractalkine的受体),具有增强的表达。另外,我们注意到IL-10可增加CX 3CR 1的表达。 与YA相比,OA中的7 R α低EM CD 8 + T细胞以及衰老对OA细胞DNA甲基化的影响。 CX 3CR 1启动子。因此,我们假设衰老“定性”地增强了亲- 人IL-7 R α通过影响基因调控机制降低EM CD 8 + T细胞的炎症特性,包括 DNA甲基化和IL-15介导的反应除了扩大它们和可溶性因子之外 由这些细胞产生的蛋白质通过激活其他细胞来促进炎症。该假设将通过以下方式进行检验: 目标1.研究衰老是否促进IL-7 R α低EM CD 8 + T细胞介导的炎症反应, 通过DNA甲基化和转录因子改变炎症基因调控;目的2. 阐明人IL-7 R α低EM CD 8 + T细胞中IL-15介导的炎症反应的年龄相关变化 细胞;和目标3.研究IL-7 R α低EM CD 8 + T细胞的年龄相关性改变的意义 使用离体生物测定和人源化小鼠促进炎症反应。我们的研究结果将揭示 扩增的记忆性CD 8 + T细胞在衰老中的生物学意义,特别是在 炎症,以及基因调控在促进这一过程中的可能作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Insoo Kang其他文献

Insoo Kang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Insoo Kang', 18)}}的其他基金

Investigating monocyte activation pathways in lupus
研究狼疮中的单核细胞激活途径
  • 批准号:
    10731104
  • 财政年份:
    2023
  • 资助金额:
    $ 36.85万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10518405
  • 财政年份:
    2021
  • 资助金额:
    $ 36.85万
  • 项目类别:
Studying alterations of T cell immune responses in the 17q12 deletion syndrome
研究 17q12 缺失综合征中 T 细胞免疫反应的变化
  • 批准号:
    10391990
  • 财政年份:
    2021
  • 资助金额:
    $ 36.85万
  • 项目类别:
Studying the impact of altered CD8+ T cell immunity in Alzheimer's disease
研究 CD8 T 细胞免疫改变对阿尔茨海默病的影响
  • 批准号:
    10119925
  • 财政年份:
    2018
  • 资助金额:
    $ 36.85万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    10443824
  • 财政年份:
    2018
  • 资助金额:
    $ 36.85万
  • 项目类别:
Aging and IL-7 mediated CD8+ T cell survival
衰老和 IL-7 介导的 CD8 T 细胞存活
  • 批准号:
    9764233
  • 财政年份:
    2018
  • 资助金额:
    $ 36.85万
  • 项目类别:
The Impact of Aging and HIV Infection on Immunologic and Transcriptomic Signatures of Influenza Vaccine Response
衰老和 HIV 感染对流感疫苗反应的免疫学和转录组学特征的影响
  • 批准号:
    10183118
  • 财政年份:
    2017
  • 资助金额:
    $ 36.85万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7938575
  • 财政年份:
    2009
  • 资助金额:
    $ 36.85万
  • 项目类别:
Studying the effects of vitamin D on FOXP3 and IL-17 expression in human CD4+ T c
研究维生素 D 对人 CD4 T c 中 FOXP3 和 IL-17 表达的影响
  • 批准号:
    7706357
  • 财政年份:
    2009
  • 资助金额:
    $ 36.85万
  • 项目类别:
Lymphoid neogenesis and CD4+T cell differentiation in primary Sjogren's syndrome
原发性干燥综合征中的淋巴新生和 CD4 T 细胞分化
  • 批准号:
    7687681
  • 财政年份:
    2009
  • 资助金额:
    $ 36.85万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.85万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了